Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.

Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE.

Clin Cancer Res. 2019 May 15;25(10):3141-3151. doi: 10.1158/1078-0432.CCR-18-2953. Epub 2019 Feb 8.

PMID:
30737244
2.

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.

Pena I, Clayman GL, Grubbs EG, Bergeron JM Jr, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME.

Head Neck. 2018 Jan;40(1):79-85. doi: 10.1002/hed.24969. Epub 2017 Oct 16.

PMID:
29044788
3.

Management of the central compartment in differentiated thyroid carcinoma.

Goepfert RP, Clayman GL.

Eur J Surg Oncol. 2018 Mar;44(3):327-331. doi: 10.1016/j.ejso.2017.09.004. Epub 2017 Sep 13. Review.

PMID:
28964612
4.

Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer.

Chinn SB, Zafereo ME, Waguespack SG, Edeiken BS, Roberts DB, Clayman GL.

Thyroid. 2017 Oct;27(10):1291-1299. doi: 10.1089/thy.2017.0203. Epub 2017 Sep 14.

PMID:
28806882
5.

VISUAL VIGNETTE.

Khan MI, Clayman GL, Waguespack SG.

Endocr Pract. 2017 Sep;23(9):1160. doi: 10.4158/EP171856.VV. Epub 2017 Apr 27. No abstract available.

PMID:
28448755
6.

Sonographic Evaluation of Intrathyroid Metastases.

Debnam JM, Kwon M, Fornage BD, Krishnamurthy S, Clayman GL, Edeiken-Monroe BS.

J Ultrasound Med. 2017 Jan;36(1):69-76. doi: 10.7863/ultra.16.02033. Epub 2016 Dec 7.

PMID:
27925648
7.

Management of Persistent or Recurrent Structural Neck Disease in Differentiated Thyroid Carcinoma: Point and Counterpoint.

Clayman GL, Steward DL.

JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):789-91. doi: 10.1001/jamaoto.2016.1114. Review. No abstract available. Erratum in: JAMA Otolaryngol Head Neck Surg. 2016 Oct 1;142(10 ):1027.

PMID:
27227323
8.

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.

George JR, Henderson YC, Williams MD, Roberts DB, Hei H, Lai SY, Clayman GL.

J Clin Endocrinol Metab. 2015 Dec;100(12):E1550-9. doi: 10.1210/jc.2015-2690. Epub 2015 Oct 13.

9.

New and emerging therapeutic options for thyroid carcinoma: A&A discussion.

Clayman GL, Wirth LJ.

Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):17. No abstract available.

PMID:
26430871
10.

Local treatment of differentiated thyroid carcinoma.

Clayman GL.

Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):6-9. No abstract available.

PMID:
26430869
11.

Development and characterization of six new human papillary thyroid carcinoma cell lines.

Henderson YC, Ahn SH, Ryu J, Chen Y, Williams MD, El-Naggar AK, Gagea M, Schweppe RE, Haugen BR, Lai SY, Clayman GL.

J Clin Endocrinol Metab. 2015 Feb;100(2):E243-52. doi: 10.1210/jc.2014-2624. Epub 2014 Nov 26.

12.

Mutational landscape of aggressive cutaneous squamous cell carcinoma.

Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, Zhang J, Seth S, Caulin C, Clayman GL, El-Naggar AK, Gibbs RA, Weber RS, Myers JN, Wheeler DA, Frederick MJ.

Clin Cancer Res. 2014 Dec 15;20(24):6582-92. doi: 10.1158/1078-0432.CCR-14-1768. Epub 2014 Oct 10.

13.

Well-differentiated thyroid cancer with aerodigestive tract invasion: Long-term control and functional outcomes.

Su SY, Milas ZL, Bhatt N, Roberts D, Clayman GL.

Head Neck. 2016 Jan;38(1):72-8. doi: 10.1002/hed.23851. Epub 2015 Apr 6.

PMID:
25204531
14.

Use of transoral sonography with an endocavitary transducer in diagnosis, fine-needle aspiration biopsy, and intraoperative localization of retropharyngeal masses.

Fornage BD, Edeiken BS, Clayman GL.

AJR Am J Roentgenol. 2014 May;202(5):W481-6. doi: 10.2214/AJR.13.11398.

PMID:
24758683
15.

Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomes.

Holsinger FC, Ramaswamy U, Cabanillas ME, Lang J, Lin HY, Busaidy NL, Grubbs E, Rahim S, Sturgis EM, Lee JE, Weber RS, Clayman GL, Rohren EM.

JAMA Otolaryngol Head Neck Surg. 2014 May;140(5):410-5. doi: 10.1001/jamaoto.2014.264.

PMID:
24700275
16.

Detection of thyroid cancer stem cells in papillary thyroid carcinoma.

Ahn SH, Henderson YC, Williams MD, Lai SY, Clayman GL.

J Clin Endocrinol Metab. 2014 Feb;99(2):536-44. doi: 10.1210/jc.2013-2558. Epub 2013 Dec 3.

17.

Src inhibitors in suppression of papillary thyroid carcinoma growth.

Henderson YC, Toro-Serra R, Chen Y, Ryu J, Frederick MJ, Zhou G, Gallick GE, Lai SY, Clayman GL.

Head Neck. 2014 Mar;36(3):375-84. doi: 10.1002/hed.23316. Epub 2013 Jun 1.

18.

Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.

Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND.

Surgery. 2012 Dec;152(6):1165-71. doi: 10.1016/j.surg.2012.08.056.

PMID:
23158186
19.

Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinoma.

Nakashima T, Yasumatsu R, Masuda M, Clayman GL, Komune S.

J Laryngol Otol. 2012 Nov;126(11):1134-7. doi: 10.1017/S0022215112001995. Epub 2012 Sep 11.

PMID:
22963824
20.

The identification of a new role for LEKTI in the skin: The use of protein 'bait' arrays to detect defective trafficking of dermcidin in the skin of patients with Netherton syndrome.

Bennett K, Heywood W, Di WL, Harper J, Clayman GL, Jayakumar A, Callard R, Mills K.

J Proteomics. 2012 Jul 16;75(13):3925-37. doi: 10.1016/j.jprot.2012.04.045. Epub 2012 May 12.

PMID:
22588119
21.

In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Moreno MA, Edeiken-Monroe BS, Siegel ER, Sherman SI, Clayman GL.

Thyroid. 2012 Apr;22(4):347-55. doi: 10.1089/thy.2011.0121. Epub 2012 Jan 26.

22.

Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.

Clayman GL, Agarwal G, Edeiken BS, Waguespack SG, Roberts DB, Sherman SI.

Thyroid. 2011 Dec;21(12):1309-16. doi: 10.1089/thy.2011.0170.

23.

Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.

Zhao M, Sano D, Pickering CR, Jasser SA, Henderson YC, Clayman GL, Sturgis EM, Ow TJ, Lotan R, Carey TE, Sacks PG, Grandis JR, Sidransky D, Heldin NE, Myers JN.

Clin Cancer Res. 2011 Dec 1;17(23):7248-64. doi: 10.1158/1078-0432.CCR-11-0690. Epub 2011 Aug 25.

24.

Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas.

Williams MD, Zhang L, Elliott DD, Perrier ND, Lozano G, Clayman GL, El-Naggar AK.

Hum Pathol. 2011 Sep;42(9):1213-20. doi: 10.1016/j.humpath.2010.12.006. Epub 2011 Mar 21.

25.

Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer.

Moreno MA, Agarwal G, de Luna R, Siegel ER, Sherman SI, Edeiken-Monroe BS, Clayman GL.

Arch Otolaryngol Head Neck Surg. 2011 Feb;137(2):157-62. doi: 10.1001/archoto.2010.254.

PMID:
21339402
26.

Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples.

Frederick MJ, VanMeter AJ, Gadhikar MA, Henderson YC, Yao H, Pickering CC, Williams MD, El-Naggar AK, Sandulache V, Tarco E, Myers JN, Clayman GL, Liotta LA, Petricoin EF 3rd, Calvert VS, Fodale V, Wang J, Weber RS.

Am J Pathol. 2011 Feb;178(2):548-71. doi: 10.1016/j.ajpath.2010.10.044.

27.

Long-term outcomes of microsurgical reconstruction for large tracheal defects.

Yu P, Clayman GL, Walsh GL.

Cancer. 2011 Feb 15;117(4):802-8. doi: 10.1002/cncr.25492. Epub 2010 Sep 24.

28.

MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo.

Henderson YC, Chen Y, Frederick MJ, Lai SY, Clayman GL.

Mol Cancer Ther. 2010 Jul;9(7):1968-76. doi: 10.1158/1535-7163.MCT-10-0062. Epub 2010 Jun 29.

29.

Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.

Santarpia L, Myers JN, Sherman SI, Trimarchi F, Clayman GL, El-Naggar AK.

Cancer. 2010 Jun 15;116(12):2974-83. doi: 10.1002/cncr.25061.

30.

New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI.

Bennett K, Callard R, Heywood W, Harper J, Jayakumar A, Clayman GL, Di WL, Mills K.

J Proteome Res. 2010 Aug 6;9(8):4289-94. doi: 10.1021/pr1003467.

PMID:
20533828
31.

Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics.

Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, Guo Z, Qiao Y, Gillenwater AM, Myers JN, Clayman GL, Weber RS, El-Naggar AK, Mao L, Lippman SM, Hong WK, Wei Q.

Clin Cancer Res. 2010 Jan 15;16(2):764-74. doi: 10.1158/1078-0432.CCR-09-2156. Epub 2010 Jan 12.

32.

Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.

Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND.

Ann Surg Oncol. 2009 Nov;16(11):3146-53. doi: 10.1245/s10434-009-0666-3.

PMID:
19727961
33.

Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.

Henderson YC, Ahn SH, Clayman GL.

Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):347-54. doi: 10.1001/archoto.2009.17.

34.

Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.

Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI.

Head Neck. 2009 Sep;31(9):1152-63. doi: 10.1002/hed.21079.

PMID:
19360746
35.

The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.

Waguespack SG, Sherman SI, Williams MD, Clayman GL, Herzog CE.

Thyroid. 2009 Apr;19(4):407-12. doi: 10.1089/thy.2008.0429.

PMID:
19355831
36.

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.

Santarpia L, Sherman SI, Marabotti A, Clayman GL, El-Naggar AK.

Hum Pathol. 2009 Jun;40(6):827-33. doi: 10.1016/j.humpath.2008.11.003. Epub 2009 Feb 5. Erratum in: Hum Pathol. 2009 Aug;40(8):1212.

PMID:
19200582
37.

Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.

Chakravarty G, Santillan AA, Galer C, Adams HP, El-Naggar AK, Jasser SA, Mohsin S, Mondal D, Clayman GL, Myers JN.

Exp Biol Med (Maywood). 2009 Apr;234(4):372-86. doi: 10.3181/0809-RM-284. Epub 2009 Jan 28.

PMID:
19176870
38.

High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.

Henderson YC, Shellenberger TD, Williams MD, El-Naggar AK, Fredrick MJ, Cieply KM, Clayman GL.

Clin Cancer Res. 2009 Jan 15;15(2):485-91. doi: 10.1158/1078-0432.CCR-08-0933.

39.

Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.

Mazumdar A, Henderson YC, El-Naggar AK, Sen S, Clayman GL.

Head Neck. 2009 May;31(5):625-34. doi: 10.1002/hed.21007.

40.

Predictors of level V metastasis in well-differentiated thyroid cancer.

Kupferman ME, Weinstock YE, Santillan AA, Mishra A, Roberts D, Clayman GL, Weber RS.

Head Neck. 2008 Nov;30(11):1469-74. doi: 10.1002/hed.20904.

PMID:
18704973
41.

Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement.

Henderson YC, Ahn SH, Kang Y, Clayman GL.

Clin Cancer Res. 2008 Aug 1;14(15):4908-4914. doi: 10.1158/1078-0432.CCR-07-1772.

42.

Surgical management of recurrent thyroid cancer.

Hessel A, Chalian AA, Clayman GL.

Neuroimaging Clin N Am. 2008 Aug;18(3):517-25, viii. doi: 10.1016/j.nic.2008.05.002. Review.

PMID:
18656032
43.

Recent advances in thyroid cancer.

Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB.

Curr Probl Surg. 2008 Mar;45(3):156-250. doi: 10.1067/j.cpsurg.2007.12.010. No abstract available.

PMID:
18346477
44.

Recent advances in thyroid cancer. In brief.

Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB.

Curr Probl Surg. 2008 Mar;45(3):149-51. doi: 10.1067/j.cpsurg.2007.12.008. No abstract available.

PMID:
18346476
45.

Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma.

Chattopadhyay C, El-Naggar AK, Williams MD, Clayman GL.

Head Neck. 2008 Aug;30(8):991-1000. doi: 10.1002/hed.20816.

PMID:
18327775
46.

An orthotopic model of papillary thyroid carcinoma in athymic nude mice.

Ahn SH, Henderson Y, Kang Y, Chattopadhyay C, Holton P, Wang M, Briggs K, Clayman GL.

Arch Otolaryngol Head Neck Surg. 2008 Feb;134(2):190-7. doi: 10.1001/archoto.2007.36.

PMID:
18283163
47.

Parotid gland oncocytosis: CT findings with histopathologic correlation.

Shellenberger TD, Williams MD, Clayman GL, Kumar AJ.

AJNR Am J Neuroradiol. 2008 Apr;29(4):734-6. doi: 10.3174/ajnr.A0938. Epub 2008 Feb 13.

48.

Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.

Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI.

Head Neck. 2008 Jul;30(7):883-8. doi: 10.1002/hed.20791.

PMID:
18213725
49.

LBP-1b, LBP-9, and LBP-32/MGR detected in syncytiotrophoblasts from first-trimester human placental tissue and their transcriptional regulation.

Henderson YC, Frederick MJ, Wang MT, Hollier LM, Clayman GL.

DNA Cell Biol. 2008 Feb;27(2):71-9.

PMID:
18004979
50.

Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.

Komatsu N, Saijoh K, Jayakumar A, Clayman GL, Tohyama M, Suga Y, Mizuno Y, Tsukamoto K, Taniuchi K, Takehara K, Diamandis EP.

J Invest Dermatol. 2008 May;128(5):1148-59. Epub 2007 Nov 8.

Supplemental Content

Loading ...
Support Center